Observable entity
|
Measurement of severe acute respiratory syndrome coronavirus 2 antibody (observable entity)
Measurement of SARS-CoV-2 antibody
Measurement of COVID-19 antibody
Measurement of 2019 novel coronavirus antibody
Measurement of 2019-nCoV antibody
Measurement of severe acute respiratory syndrome coronavirus 2 antibody
bepaling van antilichamen tegen SARS-CoV-2
bepaling van antistoffen tegen SARS-coronavirus 2
bepaling van antilichamen tegen 'Severe acute respiratory syndrome'-coronavirus 2
Id1240461000000109
StatusDefined
ComponentSevere acute respiratory syndrome coronavirus 2 antibody
TechniqueMeasurement technique